A team of Australian researchers have developed a new targeted therapeutic approach that could improve treatment for ...

Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...

Published in the journal Blood, the research focuses on finding smarter ways to treat myelofibrosis by targeting the abnormal blood cells that drive the disease using immunotherapy, rather than just ...

The early results showed that 15 of 41 evaluable patients had objective responses and 32 had stable disease with the ...

From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...

A study led by researchers at Moffitt Cancer Center found that normal cells surrounding a tumor, known as cancer-associated ...

For the past 20 years, many of the dramatic improvements in cancer outcomes can be attributed to personalized cancer treatments based upon DNA mutations in a tumor. Targeted therapies — often one pill ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...

Targeted therapies are medicines to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted therapies work ...

Scientists from the Peter the Great St. Petersburg Polytechnic University (SPbPU) have developed a new oral drug formulation ...

Novel small molecule inhibitors show promising efficacy in endometrial cancer, with ongoing trials expanding treatment ...

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...